| |
| |
|
| Insider
Information: |
Ehrlich Christopher B |
| Relationship: |
Director |
| City: |
Franklin |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
516,275 |
|
|
Indirect Shares
|
2,152,555 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$4,424,061 |
|
|
| Total
Shares |
2,668,830 |
|
|
| Total
Value |
$4,424,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomimetic Therapeutics, Inc. |
BMTI |
Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
Premium* |
|
|
Anesiva Inc |
ANSVQ |
10% Owner |
2006-02-28 |
2,237 |
2006-02-28 |
21,869 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director, 10% Owner |
2009-01-30 |
0 |
2011-09-21 |
1,983,884 |
Premium* |
|
|
Effector Therapeutics Ord Shs |
EFTR |
Director |
2022-10-04 |
35,213 |
2022-10-04 |
143,202 |
Premium* |
|
|
Phoenix Biotech Acquisition Corp. |
PBAX |
Director |
2024-02-14 |
478,825 |
2024-02-14 |
3,600 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBAX |
Phoenix Biotech Acquisiti... |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
3,600 |
3,600 |
0 |
- |
|
| PBAX |
Phoenix Biotech Acquisiti... |
Director |
– • – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
478,825 |
478,825 |
0 |
- |
|
| PBAX |
Phoenix Biotech Acquisiti... |
Director |
– • – |
2024-02-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,296,246) |
1,000,000 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-10-04 |
4 |
B |
$0.57 |
$197 |
D/D |
346 |
35,213 |
2.31 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-09-26 |
4 |
B |
$0.55 |
$10,377 |
D/D |
18,867 |
34,867 |
2.39 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-02-18 |
4 |
B |
$4.30 |
$4,300 |
D/D |
1,000 |
16,000 |
2.31 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-02-14 |
4 |
B |
$4.45 |
$8,900 |
D/D |
2,000 |
15,000 |
2.39 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-02-09 |
4 |
B |
$4.75 |
$4,750 |
D/D |
1,000 |
13,000 |
2.31 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-02-08 |
4 |
B |
$4.92 |
$4,920 |
D/D |
1,000 |
12,000 |
2.31 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-02-04 |
4 |
B |
$5.00 |
$5,000 |
D/D |
1,000 |
11,000 |
2.39 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-02-03 |
4 |
B |
$5.15 |
$25,750 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2022-01-27 |
4 |
B |
$5.30 |
$26,515 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| PBAX |
Phoenix Biotech Acquisiti... |
CEO and Secretary |
• • • |
2021-10-08 |
4 |
A |
$10.00 |
$367,330 |
I/I |
36,733 |
699,996 |
0 |
- |
|
| PBAX |
Phoenix Biotech Acquisiti... |
CEO and and SecretaryOfficer |
• • • |
2021-10-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
663,263 |
|
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • – |
2021-08-25 |
4 |
A |
$0.00 |
$0 |
I/I |
143,202 |
1,034 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Chief Executive OfficerOfficer |
• • • |
2021-01-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
545,000 |
|
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • – |
2013-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,830,253) |
0 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • – |
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,250) |
0 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • • |
2011-09-21 |
4 |
B |
$7.24 |
$1,573,122 |
I/I |
217,228 |
1,983,884 |
2.25 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • • |
2011-09-20 |
4 |
B |
$6.59 |
$3,390,274 |
I/I |
514,848 |
1,766,656 |
2.25 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • – |
2009-04-07 |
4 |
B |
$8.50 |
$8,000,005 |
I/I |
941,177 |
941,177 |
2.1 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2009-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,251,808 |
1,251,808 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • – |
2006-05-15 |
4 |
B |
$8.00 |
$10,000 |
D/D |
1,250 |
1,250 |
2.39 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • – |
2006-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
889,076 |
889,076 |
|
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • – |
2006-05-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
889,076 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
